Controversy exists as to whether arteriolar dilation after diazoxide (DZ) administration is due to a prolonged vascular effect that outlasts the presence of circulating levels of DZ or to equilibrium of arteriolar sites with circulating DZ. To resolve this question, the direct effects of DZ on the vascular resistance (VR) of the. isolated blood-perfused (constant-flow) gracilis muscle were evaluated in 44 anesthetized dogs. Intra-arterial infusions of DZ resulted in falls in vascular resistance (-35.9± 5.5 SEM %) which returned to control levels after the infusions, thus indicating that irreversible binding to arterioles or a prolonged arteriolar effect independent of plasma levels of the drug did not obtain. Decreases (-16% to -35%) in VR could also be achieved by premixing DZ in the blood perfusion reservoir at concentrations between 40 and 100 mg/L (which may be achieved clinically); thus albumin binding does not abolish the activity of DZ. Decreases in VR by DZ were not related to stimulation of beta-adrenergic receptors, alteration in N a + or K + balance, or changes in venous levels of glucose, lactate, pO 2 , pCO 2 , or pH. When norepinephrine and angiotensin II were infused during diazoxide infusions their vasoconstrictor response was attenuated. Thus DZ has a direct effect in lowering VR which is independent of measurable changes in gracilis muscle metabolism. Moreover, the VR effect of DZ is not dependent on a prolonged arteriolar effect independent of plasma concentrations of the drug.
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pharmacokinetics arteriolar receptors adrenergic receptors norepinephrine angiotensin skeletal muscle metabolism B Management of patients with malignant hypertension is a difficult therapeutic problem. Preliminary clinical observations suggest that diazoxide may become an important agent in both the acute (1) and chronic (2) treatment of severe hypertension. Despite these observations, little is known about the mechanism of action of this therapeutically promising drug.
Controversy exists as to whether arteriolar dilation after diazoxide administration is due to a prolonged vascular effect that outlasts the presence of circulating levels of diazoxide or to equilibirum of arteriolar sites with circulating diazoxide (3, 4) . Furthermore, the metabolic effects of diazoxide suggest that the drug may interact with adrenergic receptors. For example, alpha-adrenergic receptor blockade prevents the insulin-suppressing effects of diazoxide (5) and beta-adrenergic blockade with propranolol inhibits the diazoxide-induced elevation of free fatty acids (5) . It is possible that the lowering of vascular resistance once the drug reaches the arterioles may be through beta-adrenergic receptor stimulation or through production of metabolic products which are known to be vasodilators.
The purpose of this communication is to introduce data and to speculate upon: (1) the relative importance of sustained arteriolar binding versus continued elevation of plasma levels of diazoxide in lowering skeletal muscle 168 POWELL, GREEN, WHITING, SANDERS vascular resistance; and (2) the effect of the drug, if any, on skeletal muscle adrenergic receptors and metabolism. A preliminary report of the data has been made (6) .
Methods
Forty-four mongrel dogs of both sexes ranging in weight from 13 to 16 kg were anesthetized with chloralose (60 mg/kg) and urethan (600 mg/kg). The experimental preparation, which used a constant-flow perfusion pump based on that of Renkin and Rosell (7) , is shown in Figure  1 . Compressed air at 38 psi displaced highviscosity oil (viscosity 500 cs) from an oil reservoir. The flow of oil was controlled by a needle valve. The displaced oil in turn displaced an equal volume of blood from one of three blood reservoirs. The blood was maintained at 37 C with a water bath and was stirred by magnetic stirrers. The blood flowed through a stopcock, past a Statham P23db transducer, and into the cannulated right gracilis artery. The gracilis muscle, which had been isolated surgically with its tendons tied at each end, was layered with mineral oil and kept at a constant temperature (ca. 35 C) with a heat lamp. The nerve to the gracilis muscle was either kept intact for examination of reflex effects of intravenous diazoxide upon the separately perfused but innervated muscle, or was infiltrated with xylocaine and cut before observation of the direct effects of diazoxide infused into the arterial line leading to the isolated muscle.
The gracilis vein was cannulated with polyethylene tubing and the venous blood was directed past a Statham P23db transducer and through a drop ratemeter beneath which samples were collected for venous potassium and sodium determinations. In some experiments the tip of the drop ratemeter needle was placed beneath mineral oil for the collection of consecutive venous samples for pO 2 , pCO 2 , pH, glucose, and lactate determinations. The drop ratemeter was calibrated by timed collections of blood. Significant venous pressure elevations as a result of resistance in the venous cannula were not seen. In the studies on the reflex effects of intravenous diazoxide, the dog's systemic blood pressure was monitored with a Statham P23db transducer attached to a short polyethylene catheter in the left femoral artery.
Following the surgery, approximately half the dogs were given 50 mg diphenhydramine (Benadryl) intravenously to minimize the chance of a transfusion reaction before transfusion with 400 to 600 ml of donor blood. The results obtained were similar whether or not diphenhydramine had been administered. After the transfusion the blood reservoirs were filled from the cannulated left femoral artery while the dog's tracheostomy tube was flushed with 97% O 2 , 3% CO 2 . The blood in each reservoir was one-fourth diluted with lactated Ringer Injection U.S.P. containing heparin. In two experiments in two animals the blood was not diluted and dog serum albumin (Kohn Fraction 5 1 ) (6 g/100 cc plasma) was added to elevate the arterial plasma albumin concentration. In 11 experiments in 11 animals, diazoxide of known concentration was added to one reservoir while a control saline solution of the same volume, pH, and osmolality was added to a second reservoir. It was then possible to vary rapidly the concentration of diazoxide in the arterial blood perfusing the muscle by shifting from one reservoir to another which contained blood identical in all respects except for the arterial diazoxide concentration.
Arterial perfusion pressure and venous outflow were recorded on a multichannel direct-writing Sanborn oscillograph. In ten animals an on-line analogue computer allowed a continuous oscillo- iMiles Laboratories, Inc., Research Product Division, Kankakee, Illinois 60901. graph writeout of vascular resistance and percent control resistance. Vascular resistance was calculated as mm Hg perfusion pressure per milliliter of blood flow per minute per 100 g of muscle (wet weight). The plots of venous electrolyte, glucose and lactate, pO 2 , pCO 2) and pH were corrected in time for the length of venous tubing In the plots and tables the changes in these parameters were expressed relative to their control venous levels. Although the arterial ion concentration and venous outflow remained nearly constant tiiroughout any one intervention, potassium and sodium balances were calculated during and after the infusion of diazoxide. The changes in vascular resistance, venous ion concentration, skeletal muscle ion balance, venous blood gases, and pH produced by control saline infusions of the same pH and osmolality as the diazoxide were subtracted from those produced by diazoxide infusions. The decrease in vascular resistance produced by control saline infusions was consistently less than 20% of that produced by infusions of diazoxide in saline. In the tables, data for a given time interval represent the mean values for that time interval. Statistical analyses were performed using Student's t-test.
Diazoxide (Hyperstat), 2 isoproterenol hydrochloride (Isuprel, 1:5,000), norepinephrine (Levophed Bitartrate, 0.1% base), angiotensin II (Hypertensin-Ciba), and control solutions of the same pH (11.3) and osmolality (135 mOsm/L) as the diazoxide diluted in normal saline were infused with a Braun pump into the arterial line leading to the gracilis muscle. To effect a block of the alpha-adrenergic receptors, 2 cc of phenoxybenzamine (Dibenzyline, 50 mg/ml) in saline was injected into the arterial line; this blocked the pressor response to brief intra-arterial injections of norepinephrine (0.1 ml of 1 /ig/ml). For a betaadrenergic receptor block, propranolol (Inderal, 3 1.0 ml, 2.5 mg/ml) was injected into the arterial line. As described below, this beta blockade was tested with intra-arterial infusions of isoproterenol.
Plasma potassium and sodium concentrations were determined using the Technicon Autoanalyzer (flame photometry). These electrolyte determinations were found to be reproducible to within 0.05 and 1 mEq/L, respectively. Plasma lactate determinations were done by the method of Scholz and co-workers (8) and were reproducible to within 0.1 mmole/L. Blood pO 2 , PCO2, and pH determinations were done with a Radiometer (Copenhagen) Blood Micro System 2 Kindly supplied by Irving I. A. Tabachnick, Ph.D., Scherinp Corp., Bloomfield, New Jersey 07003. 3 Kindly supplied by Alex Sahagian-Edwards, M.D., Ayerst Laboratories, New York, New York 10017.
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BMS-3 and Acid-Base Analyzer PHM71. The blood gases were calibrated with humidified gas of known partial pressure and the pH by Precision Buffer Solution (Radiometer). Serum albumin concentrations were determined by paper electrophoresis.
Results

REFLEXLY MEDIATED EFFECTS OF DIAZOXIDE ON GRACILIS MUSCLE VASCULAR RESISTANCE
Fifteen brief systemic intravenous injections of diazoxide into 13 dogs resulted in consistent significant decreases in systemic blood pressure. As illustrated in Figure 2 , these changes were accompanied by substantial increases in gracilis muscle vascular resistance in the separately perfused but innervated gracilis muscles. Table 1 summarizes the data. These increases in gracilis muscle vascular resistance were sustained during the period of hypotension. In two animals the prior intra-arterial administration of phenoxybenzamine to the muscle completely blocked the reflexly mediated increase in vascular resistance.
DIRECT EFFECT OF DIAZOXIDE UPON GRACILIS MUSCLE VASCULAR RESISTANCE
Direct six-minute intra-arterial infusions of diazoxide into the gracilis muscles of ten animals resulted in substantial decreases (-7.1 ± 0.9 SEM resistance units) in vascular resistance from a mean control level of 22.1 ±2.3 resistance units. Figure 3 is an illustrative tracing showing the effect of a diazoxide infusion on gracilis muscle perfusion pressure and blood flow. Table 2 includes a summary of the data; the changes in vascular resistance produced by control saline infusions of the same pH and osmolality were subtracted from those produced by diazoxide infusions.
To assess the recovery of vascular resistance following the diazoxide infusions, gracilis muscle perfusion pressure and venous outflow were observed for 30 minutes following the termination of infusion in seven gracilis muscles. Although the diazoxide infusions decreased vascular resistance to 60. Effect of a single quick intravenous injection of 60 mg (4 mg/kg) of diazoxide. Depicted in the top two channels are the venous outflow and perfusion pressure (P.P.) of the separately perfused but innervated gracilis muscle. In the bottom channel is shown the systemic blood pressure. Note the reflexly induced increase in gracilis vascular resistance associated with the fall in systemic blood pressure.
stopped. Figure 3 is illustrative of one such infusion. Furthermore, addition of diazoxide, in concentrations which are achieved clinically (20 to 100 mg/L of plasma), to the blood perfusion reservoir produced decreases in vascular resistance which appeared dose related compared with blood perfusate from a Effect of a direct intra-arterial infusion of diazoxide (3 mg/ml, 0.0494 ml/min) on gracilis muscle venous flow and perfusion pressure (P.P.). The initial sharp increase in both perfusion pressure and in flow is due to a buildup of pressure in the drug-infusion pump line. Perfusion pressure recovered to control levels following termination of the infusion.
Effect of Intravenous Injections of Diazoxide*
control reservoir (Fig. 4) . Data from 11 animals revealed that at plasma concentrations of 20, 40, 60, and 100 mg/L vascular resistance fell to 95 ± 2 , 84 ±7, 73 ± 2 , and 65 ± 3% of control, respectively. For a given plasma concentration of diazoxide the vascular resistance effect was reproducible for periods up to two hours following the addition of the drug. Serum albumin determinations done on four of the above diazoxide-containing reservoirs revealed low concentrations of 1.2, 1.4, 1.3, and 2.2 g/100 ml compared with the normal dog albumin concentration of 2.61 ±0.37 SE g/100 ml. 4 The reservoirs had been diluted with lactated Ringer's solution. However, in two animals the decrease in vascular resistance associated with diazoxide-containing reservoirs to which dog albumin had been added to increase the plasma concentration by 6 g/100 ml were similar to those obtained in the other experiments. Figure 5 is illustrative of a tracing from one of these experiments.
Personal communication from Robert M. Lewis, D.V.M., Department of Surgery, New England Medical Center, Boston, Massachusetts. -0.00017 ± 0.00074 +0.0001 ± 0.0041 -6 . 8 ± 1.5 <0.005 *Ten six-minute diazoxide infusions (3 mg/ml, 0.05 ml/min) both before and after intra-arterial propra-nolol (1.0 ml, 2.5 mg/ml) into ten gracilis muscles. A = change from control value. NS indicates lack of statistical significance at the 0.05 level. Mean control gracilis muscle resistance before diazoxide: prepropranolol, 22.1 * 2. The gracilis vascular resistance effect of serial additions of diazoxide to one blood reservoir; the same volumes of saline of the same pH and osmolality were added to a control reservoir. Note the dose-related decrease in vascular resistance associated with plasma levels of diazoxide which are achieved clinically.
The possibility that diazoxide might lower vascular resistance by beta-adrenergic receptor stimulation was examined in ten animals. Six-minute intra-arterial infusions of diazoxide into the gracilis muscle were carried out before and after beta-adrenergic receptor blockade with propranolol. The diazoxideinduced decrease in vascular resistance before propranolol is shown on the upper right of Figure 6 (upper) and following propranolol on the upper left of Figure 6 (lower). Propranolol failed to alter the vascular resistance response to diazoxide. Table 2 summarizes the data. The decrease in vascular resistance associated with diazoxide infusions was not significantly different from that obtained following beta-adrenergic receptor blockade. In addition, the skeletal muscle potassium uptake induced by beta-adrenergic receptor stimulation (9) was not observed with the diazoxide infusions ( Fig. 6 and Table  2 ). In six of the above experiments propranolol abolished the vascular resistance decrease and the potassium uptake associated with sixminute isoproterenol infusions (10 figl'ml, 0.05 ml/min) (Fig. 6) ; the mean changes of vascular resistance and venous potassium concentration with isoproterenol preand postpropranolol were: -18.8 ± 3.3 and -3.3 ±1.7 resistance units and -0.54 ±0.06 and 0.00 ±0.13 mEq/L, respectively. In the remaining four experiments brief intra-arterial injections of isoproterenol (0.1 ml, 1 /ig/ml) produced decreases in vascular resistance prior to but not following the intra-arterial propranolol. The isoproterenol infusions and injections were carried out in the same order as depicted in Figure 6 , that is, before the first and after the last diazoxide infusion.
In five experiments in five dogs, the pressor responses to given infusions of norepinephrine were markedly attenuated during diazoxide infusions compared with both pre-and postcontrol saline infusions of the same pH and osmolality as the diazoxide. Figure 7 illustrates one of these experiments. The mean attenuation at the end of the four-minute norepinephrine infusions was -410 ± 9 resistance units.
Similarly, the vasoconstrictor response to angiotensin II, which increases skeletal muscle vascular resistance through a mechanism other than by alpha-adrenergic receptor stimulation, was attenuated during the infusion of diazoxide in three experiments in three animals. Figure 8 is illustrative: the mean attenuation at the end of the four-minute angiotensin infusions was -29 ± 9 resistance units.
INTERACTION OF DIAZOXIDE WITH SKELETAL MUSCLE ELECTROLYTE BALANCE, BLOOD GASES, AND METABOLISM
Intra-arterial infusions of diazoxide into nine gracilis muscles which were of sufficient magnitude to substantially lower vascular resistance failed to alter either sodium or potassium balance significantly ( Table 2) . Similarly, six additional intra-arterial diazoxide infusions into six gracilis muscles produced decreases in vascular resistance but failed to alter significantly skeletal muscle oxygen consumption or the venous levels of carbon dioxide, pH, glucose, or lactate ( Table 3) . Effect of infused isoproterenol (10 iig/ml, 0.0553 ml/min) and diazoxide (3 mg/ml, 0.0553 ml/min) on vascular resistance (closed circles) and venous potassium concentration (solid lines and hatched area). Top: Control. Bottom: The same muscle after beta-adrenergic receptor blockade with propranolol. Note the lack of diazoxide-induced change in potassium balance compared with that produced by isoproterenol; and note the reproducibility of the vascular resistance response to infused diazoxide following the beta-adrenergic receptor blockade. Vascular resistance effect of a norepinephrine infusion (10 fig/ml, 0 .0553 ml/min) during an infusion of diazoxide (3 mg/ml, 0.0494 ml/min). Note the substantial decrease in the norepinephrine pressor response during a diazoxide infusion compared with that obtained during control saline infusions of the same pH and osmolality.
Effect of Arterial Infusions of Diazoxide on Skeletal Muscle Vascular Resistance and Metabolism*
Discussion
The data indicate that at concentrations studied, lowering of skeletal muscle vascular resistance is dependent on maintenance of the plasma concentration of diazoxide rather than on an arteriolar effect independent of the presence of circulating diazoxide. The addition of diazoxide to blood perfusate consistently results in a decrease in vascular resistance while the arterioles are exposed to plasma levels of the drug. Furthermore, the magnitude of the vascular resistance response appears to parallel the plasma concentration of diazoxide.
Initial clinical trials with diazoxide (10) in hypertensive patients suggested that the drug must be administered rapidly intravenously to achieve an optimal antihypertensive effect even though the drug has a biological half-life of more than a day. Subsequent workers (3)
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demonstrated that diazoxide is bound to plasma albumin at concentrations of the drug that are achieved clinically. This would suggest that it was necessary to inject diazoxide rapidly in order either to produce an arteriolar smooth muscle response that would outlast the presence of high concentrations of the drug at the vascular receptor site or to bind the drug irreversibly to arteriolar receptors at a time of high plasma concentration. The latter mechanism of action does not pertain to most drugs, which are in constant equilibrium with their receptor sites.
The present data demonstrate that the prolonged arteriolar effect of the drug is not solely attributable to irreversible binding to vascular receptors or to a prolonged vascular response that outlasts the presence of the drug. With a nonrecirculating blood-perfusion system intra-arterial infusions of diazoxide Vascular resistance effect of an angiotensin II infusion (1 ng/ml, 0.0553 ml/min) during an infusion of diazoxide. Experimental design as in Figure 7 .
produced substantial decreases in vascular resistance which, however, progressively returned to control levels following termination of the infusions. The data are consonant with the recent clinical findings of Crout and coworkers (4), who found that a given dose of diazoxide was associated with the same antihypertensive effect regardless of whether the intravenous administration was rapid or slow.
The present data indicate that at high levels of plasma albumin diazoxide added to blood perfusate maintained the ability to lower vascular resistance. It is possible that the binding properties of dog albumin may differ from those of the human. However, under the conditions described diazoxide, in concentrations which are achieved clinically, was not inactivated by albumin binding.
Thus, equilibrium of circulating levels of diazoxide with arteriolar receptors appears importantly related to the effect of the drug on vascular resistance. It is not clear, however, through what mechanism resistance is lowered once the drug reaches the receptor sites. To date, biochemical (11, 12) and physiological (5) investigations have suggested a close interrelationship among the hyperglycemic action of diazoxide, the catecholamines, and adrenergic receptor stimulation. The similarity of the diazoxide-induced biochemical and circulatory changes to those produced by epinephrine has been appreciated (13) , but the possibility that the cardiovascular response to diazoxide might at least in part be mediated through the adrenergic receptors has not been extensively examined. Ramaswamy and Richardson (14) recently presented data which would suggest that following beta-adrenergic receptor blockade with propranolol, diazoxide produced less of a decrease in the total peripheral resistance of the dog than before beta blockade. Rubin and co-workers (15) and Nayler et al. (16) found that following beta-adrenergic receptor blockade, 10 mg/kg of diazoxide still lowered systemic blood pressure in the dog. It is possible that the relatively large doses of diazoxide and of epinephrine or isoproterenol used in these experiments may have at least in part competitively overcome the beta blockade. Since the preparations were otherwise reflexly intact, the results might also reflect possible central effects of the drug. The present data, however, demonstrate that under controlled hemodynamic conditions diazoxide does not lower skeletal muscle vascular resistance through stimulation of the beta-adrenergic receptors (Fig. 6 ). Not only is the diazoxideinduced decrease in vascular resistance not blocked by propranolol, but the potassium uptake associated with beta-adrenergic receptor stimulation in skeletal muscle (9) does not occur.
In contrast to the work of Nayler and associates (16) , diazoxide does appear to attenuate the pressor response to infusions of norepinephrine ( Fig. 7 ) and of angiotensin (Fig. 8 ). The finding that this effect occurs with angiotensin as well as norepinephrine suggests that the drug does not act solely by blockade of alpha-adrenergic receptors. Rather, the data suggest that the attenuation of the pressor response of both these drugs by diazoxide is due to an unrelated vasodilator effect of the latter drug. Furthermore, skeletal muscle biochemical changes which often occur in association with other vasodilating stimuli (17) are not apparent with diazoxide. Diazoxide, therefore, acts through some as yet unknown biochemical pathway to lower skeletal muscle vascular resistance. In this regard Wohl and co-workers (18) have suggested the possibility that it may act at a receptor site in the arteriole normally activated by calcium.
Thus, the precise mechanism of action of diazoxide at the arteriolar level remains to be defined. The data, however, strongly suggest that continued elevation of the plasma levels of the drug are importantly related to the continued vascular resistance effect of diazox-Circulation Research, Vol. XXVlll, February 1971 ide. They also indicate that diazoxide lowers vascular resistance primarily through equilibrium of its plasma levels with arteriolar receptor sites rather than through a prolonged vascular effect that outlasts the presence of circulating diazoxide.
